Human Genetics Society of Australasia Position Statement: Online DNA Testing.

Australia Online DNA testing consumer genomics direct-to-consumer genetic testing genetic/genomic testing personal genomic testing

Journal

Twin research and human genetics : the official journal of the International Society for Twin Studies
ISSN: 1832-4274
Titre abrégé: Twin Res Hum Genet
Pays: England
ID NLM: 101244624

Informations de publication

Date de publication:
08 2020
Historique:
pubmed: 26 8 2020
medline: 2 9 2021
entrez: 26 8 2020
Statut: ppublish

Résumé

Increasingly, consumers have been able to seek DNA testing online to explore their personal genetic information. This increased access to a range of genomic tests has raised concerns among health professionals tasked with providing guidance and support to patients requiring genetic/genomic testing. Individuals will seek genomic testing for a range of purposes; equally, the medical marketplace offers a range of different test types. The Human Genetics Society of Australasia (HGSA) published their first statement on Direct to Consumer Genetic Testing (2012 PS02). This is a revised statement, which considers developments in the field of online DNA testing, including rapid technological changes, diversity of applications and decreasing costs of testing. It draws from the first empirical nationwide study (Genioz - Genomics: National Insights of Australians) and insights from consumers with experience of this technology. The rapid adoption of these tests and the broad range of potential consequences have informed perspectives within this statement. It is the position of the HGSA that both individuals/consumers and health care professionals/providers should be supported to make informed choices about online DNA testing. This means adequate and ongoing education and resources should be available for individuals/consumers and health care professionals/providers before, during and after testing. Health care professionals/providers should be appropriately trained, have relevant experience and should be able to demonstrate (or provide evidence of) a current certification in their field of practice. This statement was ratified at the 2018 HGSA Council Meeting and was recently reviewed in 2019 for consistency with other HGSA position statements.

Identifiants

pubmed: 32838824
pii: S1832427420000675
doi: 10.1017/thg.2020.67
doi:

Substances chimiques

DNA 9007-49-2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

256-258

Auteurs

Jacqueline Savard (J)

School of Medicine, Deakin University, Geelong, Australia.

Bronwyn Terrill (B)

Garvan Institute of Medical Research, Sydney, Australia.
University of New South Wales, Sydney, Australia.

Kate Dunlop (K)

Centre for Genetics Education, Sydney, Australia.

Amanda Samanek (A)

Genetic Support Council WA, Perth, Australia.

Sylvia A Metcalfe (SA)

Murdoch Children's Research Institute, Melbourne, Australia.
Department of Paediatrics, The University of Melbourne, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH